Description:
Velasof is a fixed-dose combination of Sofosbuvir, a hepatitis C virus (HCV) nucleotide anaVelasof is a potent antiviral therapy designed to treat chronic Hepatitis C virus (HCV) infection. It combines velpatasvir and sofosbuvir, which act by blocking essential viral enzymes to halt replication.
Suitable for all major HCV genotypes, Velasof offers high cure rates with a simplified once-daily dosage. It is especially valued for its safety, minimal side effects, and convenience in achieving sustained virologic response (SVR). alog NS5B polymerase inhibitor, and Velpatasvir, an HCV NS5A inhibitor.
Share your experience with our medical product. Write a review!
20 Jan 2026
PCOS Symptoms and Management: Signs Most Women Overlook
Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.
24 Dec 2025
Patch vs Pills: Why Transdermal Patches Are the Modern Choice for Pain & Wellness
(A Deep Dive into Pain Relief Patches, Wellness Patches & Modern Drug Delivery Technology)
16 Dec 2025
Top 7 Everyday Foods That Trigger Acidity - And How Jeerafast Helps You Enjoy Meals Without the Burn
(A complete Indian-friendly guide for digestion, bloating, acidity, and natural relief)
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
